Lv31
228 积分 2022-10-28 加入
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
4天前
已完结
Genetic control of instrumental conditioning by striatopallidal neuron–specific S1P receptor Gpr6
4天前
已完结
Parkinson’s Disease
12天前
已完结
Enhancements in Parkinson's Disease Management: Leveraging Levodopa Optimization and Surgical Breakthroughs
14天前
已完结
G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease
18天前
已完结
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate
18天前
已完结
Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species
21天前
已完结
Induction of Trop-2 expression through the binding of galectin-3 to MUC1
1个月前
已完结
PankoMab: a potent new generation anti-tumour MUC1 antibody
1个月前
已完结
Surfaceome Profiling Suggests Potential of Anti-MUC1×EGFR Bispecific Antibody for Breast Cancer Targeted Therapy
1个月前
已完结
皖公网安备34019202002308
